Bard Peripheral Vascular, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$34Mgeneral payments (2019-2025)
$399Kresearch payments (2019-2025)
17,258clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $4.1M
2020 $1.9M
2021 $12M
2022 $3.7M
2023 $4.1M
2024 $4.3M
2025 $4.3M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Diagnostic Radiology $15M
Interventional Cardiology $6.2M
Vascular & Interventional Radiology $3.9M
Vascular Surgery $3.3M
Thoracic Surgery (Cardiothoracic Vascular Surgery) $1.9M
Cardiovascular Disease $1.6M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Richard Chesbrough Bingham Farms, MI Diagnostic Radiology $13,430,985.00
Craig Walker Houma, LA Interventional Cardiology $2,436,823.16
Jeffrey Carr Tyler, TX Interventional Cardiology $1,620,834.33
Richard Gitter Metairie, LA Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,489,692.93
Puneet Khanna Rancho Mirage, CA Interventional Cardiology $799,846.15
Jihad Mustapha Grand Rapids, MI Cardiovascular Disease $662,953.40
Riad Salem Chicago, IL Vascular & Interventional Radiology $398,871.90
Ziv Haskal Charlottesville, VA Vascular & Interventional Radiology $398,807.66
Stephen Hohmann Dallas, TX Vascular Surgery $390,414.49
Robert Lewandowski Chicago, IL Vascular & Interventional Radiology $318,315.33

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.